Cubist CEO Named Ernst & Young Entrepreneur of the Year® 2013 Award Winner in New England

  Cubist CEO Named Ernst & Young Entrepreneur of the Year® 2013 AwardWinner
  in New England

Business Wire

LEXINGTON, Mass. -- June 28, 2013

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that CEO Michael
W. Bonney was named an Ernst & Young Entrepreneur Of The Year^® 2013 Award New
England winner in the Life Sciences category. Winners were announced at a gala
event at the Renaissance Waterfront in Boston, Massachusetts on Wednesday,
June 26, 2013.

“I am honored to be recognized as one of the Ernst & Young Entrepreneur Of The
Year Award New England winners. It is truly humbling to be in the company of
such great leaders across the region,” said Bonney. “The award is a reflection
of all of Cubist’s employees who bring passion and dedication to our mission
of transforming patients’ lives. The award also recognizes Cubist’s dedication
to the New England area, supporting local communities through middle and high
school science, technology, engineering and math (STEM) education programs.
Our support of STEM education is an integral part of Cubist’s corporate
culture of which I am personally proud.”

Now in its 27^th year, the Ernst & Young award recognizes outstanding
high-growth entrepreneurs who demonstrate excellence and extraordinary success
in such areas as innovation, financial performance and personal commitment to
their businesses and communities.

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
research, development, and commercialization of pharmaceutical products that
address significant unmet medical needs in the acute care environment. Cubist
is headquartered in Lexington, Mass. Additional information can be found at
Cubist’s web site at

About Ernst & Young’s Entrepreneur Of The Year^®

Ernst & Young’s Entrepreneur Of The Year is the world’s most prestigious
business award for entrepreneurs. The unique award recognizes the significant
contributions of entrepreneurs who inspire others with their vision,
leadership and achievement.

About Ernst & Young

Ernst & Young is a global leader in assurance, tax, transaction and advisory
services. Worldwide, our 167,000 people are united by our shared values and an
unwavering commitment to quality. We make a difference by helping our people,
our clients and our wider communities achieve their potential. For more
information, please visit


Cubist Pharmaceuticals, Inc.
Eileen C. McIntyre, 781-860-8533
Vice President, Investor Relations
Cubist Pharmaceuticals, Inc.
Julie DiCarlo, 781-860-8063
Senior Director, Corporate Communications
Press spacebar to pause and continue. Press esc to stop.